Kondratyeva E I, Zhekaite E K, Odinaeva N D, Voronkova A Yu, Sherman V D, Loshkova E V, Mel'yanovskaya Yu L, Zod'binova A E, Shubina Yu F, Budzinsky R M
Research Centre for Medical Genetics, 115522, Moscow, Russian Federation.
Vopr Pitan. 2020;89(2):90-99. doi: 10.24411/0042-8833-2020-10019. Epub 2020 Mar 16.
Vitamin D deficiency is widespread in patients with cystic fibrosis (CF). From 2016 to 2018, prophylactic doses of vitamin D were prescribed for the patients of the Russian cystic fibrosis Center in accordance with the National cystic fibrosis consensus and they were informed about the role of vitamin D deficiency. of the study was to conduct a comparative analysis of the frequency of deficiency and insufficiency of vitamin D in children with CF of different ages in Moscow region in 2016 and 2018. . The study involved 115 patients with CF at the age of 0-18 in 2016 and 211 children of the same age in 2018. All children underwent determination of 25(OH)D in blood serum by ELISA. . The frequency of vitamin D deficiency and insufficiency [25(OH)D level <30 ng/ml] in CF patients in 2016 was 64.3%, and in 2018 - 48.7%. Among children of 0-3 years normal serum 25(OH)D levels (>30 ng/ml) were registered in 62.5% in 2016 and in 62.2% in 2018, in children of 4-11 years - 28.8% in 2016 and 58.1% in 2018, among adolescents (11-18 years) - 11.8 and 30.2%, respectively. . Comparative analysis showed a positive dynamics in reducing the proportion of CF patients with vitamin D deficiency and insufficiency against the background of continuous use of prophylactic doses of cholecalciferol and educational work for the period from 2016 to 2018. However, in a significant proportion of patients (48.7%), vitamin D level did not reach the norm in 2018 that requires the correction of preventive doses and increase in patient compliance.
维生素D缺乏在囊性纤维化(CF)患者中很普遍。2016年至2018年,俄罗斯囊性纤维化中心的患者根据国家囊性纤维化共识接受了预防性剂量的维生素D治疗,并被告知维生素D缺乏的影响。本研究的目的是对2016年和2018年莫斯科地区不同年龄的CF儿童中维生素D缺乏和不足的频率进行比较分析。该研究纳入了2016年115名0至18岁的CF患者和2018年211名同年龄段儿童。所有儿童均通过酶联免疫吸附测定法(ELISA)测定血清25(OH)D。2016年CF患者中维生素D缺乏和不足[25(OH)D水平<30 ng/ml]的频率为64.3%,2018年为48.7%。在0至3岁的儿童中,2016年正常血清25(OH)D水平(>30 ng/ml)的比例为62.5%,2018年为62.2%;在4至11岁的儿童中,2016年为28.8%,2018年为58.1%;在青少年(11至18岁)中,分别为11.8%和30.2%。比较分析显示,在2016年至2018年期间持续使用预防性剂量的胆钙化醇并开展教育工作的背景下,CF患者维生素D缺乏和不足的比例呈积极下降趋势。然而,2018年仍有相当比例的患者(48.7%)维生素D水平未达到正常范围,这需要调整预防剂量并提高患者的依从性。